Cleared Traditional

LIPOCONTROL (K090754) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K090754 · Osyris Medical · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
672d
Days
Class 2
Risk

K090754 is an FDA 510(k) clearance for the LIPOCONTROL. Classified as Laser Assisted Lipolysis (product code ORK), Class II - Special Controls.

Submitted by Osyris Medical (France, FR). The FDA issued a Cleared decision on January 21, 2011 after a review of 672 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Osyris Medical devices

Submission Details

510(k) Number K090754 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 2009
Decision Date January 21, 2011
Days to Decision 672 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
557d slower than avg
Panel avg: 115d · This submission: 672d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ORK Laser Assisted Lipolysis
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition Intended To Be Used For Laser Assisted Lipolysis
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.